People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Proteogenix Inc | — | Biotechnology | Series A | $8.0M | $144.6M | 2009 |
Robert M. DiTullio at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert M. DiTullio on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Fred Cohen | 1 | 12 |
| Vijay Lathi | 1 | 8 |
| G. Steven Burrill | 1 | 7 |
| David Levison | 1 | 3 |
| Mike Allen | 1 | 3 |
| Fred G. Cohen | 1 | 3 |
| Srinivasa Nagalla | 1 | 1 |
| Thomas E. Grove | 1 | 1 |
| David G. Levison | 1 | 1 |
| Vijay G. Lathi | 1 | 1 |
| Durlin E. Hickok | 1 | 1 |
| Thomas H. Grove | 1 | 1 |
| Richard Creager | 1 | 1 |
| Donald Mooney | 1 | 1 |
| Mike E. Allen | 1 | 1 |
| Steven G. Burrill | 1 | 1 |
| Michael G. Gravett | 1 | 1 |
| Richard G. Creager | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.